Jasper Therapeutics Stock Price Prediction

JSPR Stock  USD 22.05  0.21  0.96%   
The RSI of Jasper Therapeutics' the stock price is slightly above 69. This indicates that the stock is rather overbought by investors as of today. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Jasper, making its price go up or down.

Oversold Vs Overbought

69

 
Oversold
 
Overbought
The successful prediction of Jasper Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Jasper Therapeutics and does not consider all of the tangible or intangible factors available from Jasper Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Jasper Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Jasper Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(1.10)
EPS Estimate Current Year
(4.48)
EPS Estimate Next Year
(4.45)
Wall Street Target Price
69.5
EPS Estimate Current Quarter
(1.07)
Using Jasper Therapeutics hype-based prediction, you can estimate the value of Jasper Therapeutics from the perspective of Jasper Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Jasper Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Jasper because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Jasper Therapeutics after-hype prediction price

    
  USD 22.42  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Jasper Therapeutics Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.
Intrinsic
Valuation
LowRealHigh
7.2812.3124.26
Details
Naive
Forecast
LowNextHigh
14.9920.0225.04
Details
10 Analysts
Consensus
LowTargetHigh
6.377.007.77
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.16-1.12-1.06
Details

Jasper Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Jasper Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Jasper Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Jasper Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Jasper Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Jasper Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Jasper Therapeutics' historical news coverage. Jasper Therapeutics' after-hype downside and upside margins for the prediction period are 17.39 and 27.45, respectively. We have considered Jasper Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
22.05
22.42
After-hype Price
27.45
Upside
Jasper Therapeutics is moderately volatile at this time. Analysis and calculation of next after-hype price of Jasper Therapeutics is based on 3 months time horizon.

Jasper Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Jasper Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Jasper Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Jasper Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.26 
5.03
  0.37 
  0.02 
8 Events / Month
11 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
22.05
22.42
1.68 
356.74  
Notes

Jasper Therapeutics Hype Timeline

Jasper Therapeutics is currently traded for 22.05. The entity has historical hype elasticity of 0.37, and average elasticity to hype of competition of 0.02. Jasper is projected to increase in value after the next headline, with the price projected to jump to 22.42 or above. The average volatility of media hype impact on the company the price is over 100%. The price gain on the next news is projected to be 1.68%, whereas the daily expected return is currently at 0.26%. The volatility of related hype on Jasper Therapeutics is about 7672.88%, with the expected price after the next announcement by competition of 22.07. Net Loss for the year was (64.47 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next projected press release will be in about 8 days.
Check out Jasper Therapeutics Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.

Jasper Therapeutics Related Hype Analysis

Having access to credible news sources related to Jasper Therapeutics' direct competition is more important than ever and may enhance your ability to predict Jasper Therapeutics' future price movements. Getting to know how Jasper Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Jasper Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
LYRALyra Therapeutics(0.01)4 per month 0.00 (0.10) 8.00 (10.00) 41.07 
EQEquillium(0.02)8 per month 0.00 (0.03) 15.25 (9.35) 64.12 
HOOKHookipa Pharma 0.09 7 per month 0.00 (0.36) 4.05 (7.24) 22.98 
LIANLianBio ADR 0.00 0 per month 3.34  0.01  6.76 (5.00) 20.98 
ABOSAcumen Pharmaceuticals(0.10)4 per month 0.00 (0.06) 7.52 (6.67) 28.07 
GRTXGalera Therapeutics(0.02)1 per month 0.00 (0.04) 7.31 (5.84) 18.16 
INZYInozyme Pharma(0.03)8 per month 0.00 (0.27) 5.68 (7.92) 16.62 
ELDNEledon Pharmaceuticals 0.17 5 per month 3.04  0.09  10.09 (4.24) 28.12 
ICVXIcosavax(0.11)1 per month 4.56  0.13  10.22 (6.79) 38.57 
EWTXEdgewise Therapeutics 0.32 10 per month 2.85  0.11  6.65 (4.70) 61.02 
IKNAIkena Oncology(0.05)4 per month 1.39 (0.07) 1.81 (1.74) 13.50 
DSGNDesign Therapeutics(0.24)5 per month 5.31  0.04  9.61 (8.21) 35.31 
XLOXilio Development 0.03 5 per month 6.20  0.02  10.10 (10.99) 57.76 
ELYMEliem Therapeutics 0.25 4 per month 0.00 (0.20) 6.21 (9.35) 34.87 
PNTPOINT Biopharma Global 0.00 0 per month 2.58  0.03  5.70 (3.78) 20.11 
ORICOric Pharmaceuticals 0.03 8 per month 4.26  0  6.04 (5.18) 23.18 
INBXInhibrx 1.00 6 per month 2.71  0.01  4.92 (6.11) 16.80 
EPIXESSA Pharma(0.13)9 per month 0.00 (0.08) 9.30 (6.45) 84.61 

Jasper Therapeutics Additional Predictive Modules

Most predictive techniques to examine Jasper price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Jasper using various technical indicators. When you analyze Jasper charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Jasper Therapeutics Predictive Indicators

The successful prediction of Jasper Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Jasper Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Jasper Therapeutics based on analysis of Jasper Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Jasper Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Jasper Therapeutics's related companies.
 2021 2022 2023 2024 (projected)
Current Ratio10.955.917.199.43
Net Debt To EBITDA2.630.911.291.23

Story Coverage note for Jasper Therapeutics

The number of cover stories for Jasper Therapeutics depends on current market conditions and Jasper Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Jasper Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Jasper Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Jasper Therapeutics Short Properties

Jasper Therapeutics' future price predictability will typically decrease when Jasper Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Jasper Therapeutics often depends not only on the future outlook of the potential Jasper Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Jasper Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding10.4 M
Cash And Short Term Investments86.9 M

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.